Ironwood Pharmaceuticals Inc IRWD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:02 AM EDT
7.82UNCH (UNCH)
Volume
231,760
52 week range
7.53 - 15.70
Loading...
  • Open7.85
  • Day High7.97
  • Day Low7.80
  • Prev Close7.82
  • 52 Week High15.70
  • 52 Week High Date02/14/24
  • 52 Week Low7.53
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap1.224B
  • Shares Out156.53M
  • 10 Day Average Volume2.61M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-31.25

KEY STATS

  • Open7.85
  • Day High7.97
  • Day Low7.80
  • Prev Close7.82
  • 52 Week High15.70
  • 52 Week High Date02/14/24
  • 52 Week Low7.53
  • 52 Week Low Date04/18/24
  • Market Cap1.224B
  • Shares Out156.53M
  • 10 Day Average Volume2.61M
  • Dividend-
  • Dividend Yield-
  • Beta0.57
  • YTD % Change-31.25

RATIOS/PROFITABILITY

  • EPS (TTM)-6.51
  • P/E (TTM)-1.20
  • Fwd P/E (NTM)10.06
  • EBITDA (TTM)169.911M
  • ROE (TTM)-654.88%
  • Revenue (TTM)442.735M
  • Gross Margin (TTM)27.85%
  • Net Margin (TTM)-233.00%
  • Debt To Equity (MRQ)-201.52%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ironwood Pharmaceuticals Inc

 

Profile

MORE
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of functional constipation in pediatric patients ages 6-17 years old. It is advancing...
Julie Mchugh
Independent Chairman of the Board
Thomas Mccourt
Chief Executive Officer, Director
Sravan Emany
Chief Financial Officer, Senior Vice President
Address
100 Summer Street, Suite 2300
Boston, MA
02110
United States

Top Peers

SYMBOLLASTCHG%CHG
ANIP
ANI Pharmaceuticals Inc
65.46+0.10+0.15%
COLL
Collegium Pharmaceutical Inc
36.86+0.44+1.21%
INVA
Innoviva Inc
15.23-0.03-0.20%
PCRX
Pacira Biosciences Inc
26.30-0.03-0.11%
HRMY
Harmony Biosciences Holdings Inc
29.71+0.39+1.33%